EUVIMEDEUVIMED entdecken
Open Access

PSAP‐Genomic‐Regions: A Method Leveraging Population Data to Prioritize Coding and Non‐Coding Variants in Whole Genome Sequencing for Rare Disease Diagnosis

Marie-Sophie C Ogloblinsky, Ozvan Bocher, Chaker Aloui, Anne-Louise Leutenegger, Ozan Ozisik, Anaïs Baudot, Elisabeth Tournier-Lasserve, Helen Castillo-Madeen, Daniel Lewinsohn, Donald F Conrad, Emmanuelle Génin, Gaëlle Marenne

Genetic Epidemiology · 2025

DOI: 10.1002/gepi.22593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Epidemiology, 2025. Verfasst von Marie-Sophie C Ogloblinsky und 11 weiteren Autor:innen. Beteiligte Einrichtung: Univ Brest, Inserm, EFS, UMR 1078, GGB, Brest, France. Hauptthemen laut MEDLINE: Rare Diseases, Whole Genome Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, This study was jointly supported by the French Priority Research Program on Rare Diseases "Programme Prioritaire de Recherche Maladies Rares du Programme franç….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The introduction of Next‐Generation Sequencing technologies in the clinics has improved rare disease diagnosis. Nonetheless, for very heterogeneous or very rare diseases, more than half of cases still lack molecular diagnosis. Novel strategies are needed to prioritize variants within a single individual. The Population Sampling Probability (PSAP) method was developed to meet this aim but only for coding variants in exome data. Here, we propose an extension of the PSAP method to the non‐coding genome called PSAP‐genomic‐regions. In this extension, instead of considering genes as testing units (PSAP‐genes strategy), we use genomic regions defined over the whole genome that pinpoint potential functional constraints. We conceived an evaluation protocol for our method using artificially generated disease exomes and genomes, by inserting coding and non‐coding pathogenic ClinVar variants in large data sets of exomes and genomes from the general population. PSAP‐genomic‐regions significantly improves the ranking of these variants compared to using a pathogenicity score alone. Using PSAP‐genomic‐regions, more than 50% of non‐coding ClinVar variants were among the top 10 variants of the genome. On real sequencing data from six patients with Cerebral Small Vessel Disease and nine patients with male infertility, all causal variants were ranked in the top 100 variants with PSAP‐genomic‐regions. By revisiting the testing units used in the PSAP method to include non‐coding variants, we have developed PSAP‐genomic‐regions, an efficient whole‐genome prioritization tool which offers promising results for the diagnosis of unresolved rare diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesWhole Genome SequencingHumansGenetic VariationExomeHigh-Throughput Nucleotide SequencingGenome, HumanGenomicsGenetics, Population

Stichwörter der Autor:innen

non‐coding variantsrare diseasesvariant prioritizationwhole‐genome sequencing

Autor:innen und Institutionen

  • Univ Brest, Inserm, EFS, UMR 1078, GGB, Brest, France.
  • Institute of Translational Genomics, Helmholtz Zentrum München, Munich, Germany.
  • Inserm, NeuroDiderot, Unité Mixte de Recherche, Université Paris Cité, Paris, France.
  • INSERM, Marseille Medical Genetics (MMG), Aix Marseille University, Marseille, France.
  • Assistance Publique-Hôpitaux de Paris, Service de Génétique Moléculaire Neurovasculaire, Hôpital Saint-Louis, Paris, France.
  • Division of Genetics, Oregon National Primate Research Center, Oregon Health and Science University, Portland, Oregon, USA.

Förderung

  • NICHD NIH HHS
  • This study was jointly supported by the French Priority Research Program on Rare Diseases "Programme Prioritaire de Recherche Maladies Rares du Programme franç…

Zitieren

APA

Ogloblinsky, M. C., Bocher, O., Aloui, C., Leutenegger, A. L., Ozisik, O., Baudot, A., Tournier-Lasserve, E., Castillo-Madeen, H., Lewinsohn, D., Conrad, D. F., Génin, E., & Marenne, G. (2025). PSAP‐Genomic‐Regions: A Method Leveraging Population Data to Prioritize Coding and Non‐Coding Variants in Whole Genome Sequencing for Rare Disease Diagnosis. Genetic Epidemiology. https://doi.org/10.1002/gepi.22593

Vancouver

Ogloblinsky MC, Bocher O, Aloui C, Leutenegger AL, Ozisik O, Baudot A, et al. PSAP‐Genomic‐Regions: A Method Leveraging Population Data to Prioritize Coding and Non‐Coding Variants in Whole Genome Sequencing for Rare Disease Diagnosis. Genetic Epidemiology. 2025. doi:10.1002/gepi.22593

BibTeX
@article{Ogloblinsky2025,
  author = {Ogloblinsky, Marie-Sophie C and Bocher, Ozvan and Aloui, Chaker and Leutenegger, Anne-Louise and Ozisik, Ozan and Baudot, Anaïs and Tournier-Lasserve, Elisabeth and Castillo-Madeen, Helen and Lewinsohn, Daniel and Conrad, Donald F and Génin, Emmanuelle and Marenne, Gaëlle},
  title = {PSAP‐Genomic‐Regions: A Method Leveraging Population Data to Prioritize Coding and Non‐Coding Variants in Whole Genome Sequencing for Rare Disease Diagnosis},
  journal = {Genetic Epidemiology},
  year = {2025},
  doi = {10.1002/gepi.22593}
}
Kostenlos starten →